CORONAVIRUS Resources

Additional Information

Continuing Education Opportunities Related to COVID-19

• APhA COVID-19 Resources and Training
• ASHP Critical Care Pharmacy Review Course
• PharmacyTimes COVID-19 Continuing Education
  • Free, ACPE-accredited CE offered on-demand or through scheduled enrollable webinars

Workplace Planning Tools

• ASHP Daily COVID-19 Podcast
• Implementing Safety Practices for Workers with Confirmed or Suspected Exposure to COVID-19
• Emergency Care Research Institute COVID-19 Preparedness Center & Safe Medication Practices
• ASHP COVID-19 PANDEMIC ASSESSMENT TOOL for Health-System Pharmacy Departments
• ASPR COVID-19 Healthcare Planning Checklist
• CDC Guidance for Businesses
  

Reputable Medical Societies Pages

• American College of Cardiology COVID-19 Hub
• Up-to-Date Society guideline links: Coronavirus disease 2019 (COVID-19)
• The New England Journal of Medicine Coronavirus (Covid-19) - A free collection of articles and other resources on the Coronavirus (Covid-19) outbreak, including clinical reports, management guidelines, and commentary.
• Infectious Diseases Society of America
• The Sanford Guide Coronavirus, COVID-19, SARS

Pharmaceutical Treatment Resources

• Treatment Guideline from NIH
  
• Treatment Guideline from the IDSA
• Treatment Resources from Mass General Hospital
  
• John’s Hopkins Clinical Guidance for Available Pharmacologic Therapies for COVID-19
• UW Medicine Interim Treatment Guidelines for SARS-CoV-2 Infection/COVID-19
• Brigham and Women’s Hospital COVID-19 Critical Care Clinical Guidelines
• Joint Statement of the American Medical Association, American Pharmacists Association, and American Society of Health-System Pharmacists on Inappropriate Ordering, Prescribing or Dispensing of Medications to Treat COVID-19
• COVID-19 Treatment: A Review of Early and Emerging Options
• Review: Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
• Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
• Nebraska Medicine COVID-19 Antiviral and Pharmacotherapy Recommendations
• CDC Information for Clinicians on Therapeutic Options for COVID-19 Patients
• University of Michigan Medicine – Inpatient Guidance for Diagnosis and treatment of COVID-19 in Adults and Children
• UKID Pharmacotherapy Guidance for Adult Patients Positive for COVID-19

Pharmaceutical Research Resources

• Study tests hydroxychloroquine and azithromycin use in 80 COVID-19 patients (4/17/20)
  
• WHO launches global megatrial (SOLIDARITY Trial)  (4/13/20)
• Hydroxycloroquine Clinical Trial (4/9/20)
• FDA Investigational COVID-19 Convalescent Plasma - Emergency INDs (3/24/20)
• NIH Clinical Trial of Investigational Vaccine (3/30/20)
• Genentech Launches Phase III Trial of Actemra as Coronavirus Treatment (3/19/20)
• Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non-randomized clinical trial (3/16/20)
• NIH clinical trial of remdesivir to treat COVID-19 begins (2/25/20)

• CDC Coronavirus Self-Checker
• The President’s Coronavirus Guidelines for America
• CDC - What to do if you are sick with coronavirus disease 2019 (COVID-19) 1-pager
• IDSA - Staying Safe While Out in Public
• IDSA - What the Experts Say about COVID-19 Risks
• IDSA - Taking Care of Your Mental Health during COVID-19
• IDSA - How to Wear Face Coverings and Masks
  

Resources for Parents/Children

• SAMHSA - Talking with Children: Tips for caregivers, parents, and teachers during infectious disease outbreaks
• NASP & NASN - Talking to Children About COVID-19 (Coronavirus) A Parent Resource

Association Pages

• APhA Pharmacists’ Guide to Coronavirus
• ASHP Coronavirus Disease 2019 (COVID-19)
• NCPA Coronavirus Disease 2019 (COVID-19)

Governmental COVID-19 Resources

• EPA - List N: Disinfectants for Use Against SARS-CoV-2
• Coronavirus (COVID-19) – Resources compiled for the public by The White House, the Department of Health and Human Services and the CDC
• Occupational Safety and Health Administration
• U.S. Department of Labor
• Centers for Disease Control
• Kansas Department of Health & Environment
• Information for Healthcare Professionals from the CDC
  
• Information from World Health Organization
• U.S. Food and Drug Administration Coronavirus Disease 2019 (COVID-19)
• Centers for Medicare & Medicaid Services Partner Toolkit
• National Institutes of Health Coronavirus (COVID-19)
• National Institute of Allergies & Infectious Diseases Coronaviruses
• U.S. Small Business Administration Disaster Assistance

State Price-Gouging Law Now in Effect

A Kansas law that prohibits profiteering by raising prices on items consumers find necessary because of the COVID-19 virus outbreak is in effect statewide.

The law generally prohibits unjustifiably raising prices for goods and services for which consumer demand is likely to increase because of the virus outbreak. A price increase is presumed unjustified if it exceeds by 25 percent or more the price at which the goods or services were available on March 11 or the price for which the same goods or services are available from other sellers in the trade area.

Examples of consumer goods and services governed by the anti-profiteering law include, but are not limited to, food items, sanitary and cleaning supplies such as hand sanitizer and disinfecting wipes, emergency supplies, medical supplies and services, lodging, and any other property or service for which consumer demand may increase in response to the virus outbreak. The law carries a penalty of up to $10,000 per violation.

KPhA reminds pharmacy owners and managers that if they suspect any price-gouging measures happening in relation to their purchase of pharmaceutical products from wholesalers or other sources to please contact the Attorney General's Consumer Protection Division at www.InYourCornerKansas.org or call (800) 432-2310 to request a paper complaint form be sent by mail.